For the Inventor, By the Inventor

Enter assignee name

Palatine, IL, United States of America

Acura Pharmaceuticals, Inc.

USPTO Granted Patents = 30

CIPO Patents = 11

EPO Patents = 5

Trademarks = 4

Forward Citations = 951

Loading Chart...

Loading Chart...

18 inventors (with patents filed for the assignee):

Albert W Brzeczko (10 out of 13 patents)

Vijai Kumar (10 out of 17 patents)

David Dixon (9 out of 21 patents)

4. Dilip B Wadgaonkar (9 out of 9 patents)

5. Divya Tewari (9 out of 13 patents)

6. Ronald L Leech, Jr (7 out of 7 patents)

7. R Gary Hollenbeck (6 out of 7 patents)

8. Rachelle L Hall Yung (3 out of 3 patents)

9. Igor R Likhotvorik (3 out of 3 patents)

10. Charles Auxilium Francis (3 out of 6 patents)

11. Robert Barnett Jones (2 out of 4 patents)

12. Joseph J Lisowski (2 out of 2 patents)

13. Zhaiwei Lin (1 out of 3 patents)

14. Christopher Arne Kaldahl (1 out of 3 patents)

15. Kazimierz Grzegorz Antczak (1 out of 7 patents)

30 patents: Sort by Forward Citations

1. 11857629 - Methods and compositions for self-regulated release of active pharmaceutical ingredient (2024-01-02),

2. 11723885 - Methods and compositions for interfering with extraction or conversion of a drug susceptible to abuse (2023-08-15),

3. 11554114 - Methods and compositions for self-regulated release of active pharmaceutical ingredients (2023-01-17),

4. 11197837 - Methods and compositions for interfering with extraction or conversion of a drug susceptible to abuse (2021-12-14),

5. 11103581 - Methods and compositions for self-regulated release of active pharmaceutical ingredient (2021-08-31),

6. 11083794 - Methods and compositions for self-regulated release of active pharmaceutical ingredient (2021-08-10),

7. 10688184 - Methods and compositions for self-regulated release of active pharmaceutical ingredient (2020-06-23),

8. 10610497 - Methods and compositions for interfering with extraction or conversion of a drug susceptible to abuse (2020-04-07),

9. 10155044 - Methods and compositions for deterring abuse (2018-12-18),

10. 10004699 - Methods and compositions for interfering with extraction or conversion of a drug susceptible to abuse (2018-06-26),

11. 9757466 - Methods and compositions for deterring abuse (2017-09-12),

12. 9662393 - Methods and compositions for self-regulated release of active pharmaceutical ingredient (2017-05-30),

13. 9492443 - Abuse deterrent compositions and methods of making same (2016-11-15),

14. 9320796 - Methods and compositions for self-regulated release of active pharmaceutical ingredient (2016-04-26),

15. 9101636 - Methods and compositions for self-regulated release of active pharmaceutical ingredient (2015-08-11),

Acura Pharmaceuticals, Inc. is a pharmaceutical company dedicated to developing and commercializing innovative abuse deterrent products to address the growing problem of prescription drug abuse. With a focus on creating technologies that make prescription drugs more difficult to abuse, Acura aims to protect patients while still providing effective pain management solutions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

30 Patents

#5 in Palatine, IL

#585 in Illinois

#10,859 in US

#21,181 in the World

Palatine, IL, United States of America

Acura Pharmaceuticals, Inc.

Forward Citations = 951

18 inventors:

Albert W Brzeczko (10 out of 13 patents)

Vijai Kumar (10 out of 17 patents)

David Dixon (9 out of 21 patents)

4. Dilip B Wadgaonkar (9 out of 9 patents)

5. Divya Tewari (9 out of 13 patents)

Please report any incorrect information to support@idiyas.com

Loading…